
The global market for Genetically Modified Experimental Animal Model was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
In 2020, the estimated global market size of model animal sales is USD 8.1 billion, and the global market for model animal sales is expected to grow at a CAGR of 9.4% from 2020 to 2025,and further grow at a CAGR of 7.0% from 2025 to 2030, reaching USD 17.8 billion in 2030.
This report aims to provide a comprehensive presentation of the global market for Genetically Modified Experimental Animal Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Modified Experimental Animal Model.
The Genetically Modified Experimental Animal Model market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetically Modified Experimental Animal Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetically Modified Experimental Animal Model companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Joinn Laboratories (China) Co., Ltd.
Pharmaron Inc.
Shanghai Model Organisms Center, Inc.
Sichuan Hengshu Bio-Technology Co.,Ltd.
China Environmental Technology and Bioenergy Holdings Limited
GemPharmatech Co., Ltd.
Beijing Vital River Laboratory Animal Technology Co., Ltd.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Jackson Laboratory
Hainan Jinlinggang Biotechnology Co., Ltd.
Guangdong Landau Biotechnology Co. Ltd.
Hubei Topgene Biotechnology Co., Ltd.
Envigo
Shanghai Slack Experimental Animal Co., Ltd.
Janvier Labs
Taconic Biosciences
Charles River Laboratories
Institute Of Beijing Xieerxin Biology Resource Co.ltd
PolyGene
Cyagen Biosciences
Biocytogen
Hera BioLabs
Ozgene
Segment by Type
Genetically Modified Mice
Genetically Modified Rats
Genetically Modified Zebrafish
Others
Segment by Application
Pharmaceutical
Scientific Research
Education
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetically Modified Experimental Animal Model company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetically Modified Experimental Animal Model Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetically Modified Mice
1.2.3 Genetically Modified Rats
1.2.4 Genetically Modified Zebrafish
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genetically Modified Experimental Animal Model Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.3.4 Education
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetically Modified Experimental Animal Model Market Perspective (2020-2031)
2.2 Global Genetically Modified Experimental Animal Model Growth Trends by Region
2.2.1 Global Genetically Modified Experimental Animal Model Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genetically Modified Experimental Animal Model Historic Market Size by Region (2020-2025)
2.2.3 Genetically Modified Experimental Animal Model Forecasted Market Size by Region (2026-2031)
2.3 Genetically Modified Experimental Animal Model Market Dynamics
2.3.1 Genetically Modified Experimental Animal Model Industry Trends
2.3.2 Genetically Modified Experimental Animal Model Market Drivers
2.3.3 Genetically Modified Experimental Animal Model Market Challenges
2.3.4 Genetically Modified Experimental Animal Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetically Modified Experimental Animal Model Players by Revenue
3.1.1 Global Top Genetically Modified Experimental Animal Model Players by Revenue (2020-2025)
3.1.2 Global Genetically Modified Experimental Animal Model Revenue Market Share by Players (2020-2025)
3.2 Global Genetically Modified Experimental Animal Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genetically Modified Experimental Animal Model Revenue
3.4 Global Genetically Modified Experimental Animal Model Market Concentration Ratio
3.4.1 Global Genetically Modified Experimental Animal Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetically Modified Experimental Animal Model Revenue in 2024
3.5 Global Key Players of Genetically Modified Experimental Animal Model Head office and Area Served
3.6 Global Key Players of Genetically Modified Experimental Animal Model, Product and Application
3.7 Global Key Players of Genetically Modified Experimental Animal Model, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetically Modified Experimental Animal Model Breakdown Data by Type
4.1 Global Genetically Modified Experimental Animal Model Historic Market Size by Type (2020-2025)
4.2 Global Genetically Modified Experimental Animal Model Forecasted Market Size by Type (2026-2031)
5 Genetically Modified Experimental Animal Model Breakdown Data by Application
5.1 Global Genetically Modified Experimental Animal Model Historic Market Size by Application (2020-2025)
5.2 Global Genetically Modified Experimental Animal Model Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genetically Modified Experimental Animal Model Market Size (2020-2031)
6.2 North America Genetically Modified Experimental Animal Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genetically Modified Experimental Animal Model Market Size by Country (2020-2025)
6.4 North America Genetically Modified Experimental Animal Model Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetically Modified Experimental Animal Model Market Size (2020-2031)
7.2 Europe Genetically Modified Experimental Animal Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genetically Modified Experimental Animal Model Market Size by Country (2020-2025)
7.4 Europe Genetically Modified Experimental Animal Model Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetically Modified Experimental Animal Model Market Size (2020-2031)
8.2 Asia-Pacific Genetically Modified Experimental Animal Model Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genetically Modified Experimental Animal Model Market Size by Region (2020-2025)
8.4 Asia-Pacific Genetically Modified Experimental Animal Model Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetically Modified Experimental Animal Model Market Size (2020-2031)
9.2 Latin America Genetically Modified Experimental Animal Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genetically Modified Experimental Animal Model Market Size by Country (2020-2025)
9.4 Latin America Genetically Modified Experimental Animal Model Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetically Modified Experimental Animal Model Market Size (2020-2031)
10.2 Middle East & Africa Genetically Modified Experimental Animal Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genetically Modified Experimental Animal Model Market Size by Country (2020-2025)
10.4 Middle East & Africa Genetically Modified Experimental Animal Model Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Joinn Laboratories (China) Co., Ltd.
11.1.1 Joinn Laboratories (China) Co., Ltd. Company Details
11.1.2 Joinn Laboratories (China) Co., Ltd. Business Overview
11.1.3 Joinn Laboratories (China) Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.1.4 Joinn Laboratories (China) Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.1.5 Joinn Laboratories (China) Co., Ltd. Recent Development
11.2 Pharmaron Inc.
11.2.1 Pharmaron Inc. Company Details
11.2.2 Pharmaron Inc. Business Overview
11.2.3 Pharmaron Inc. Genetically Modified Experimental Animal Model Introduction
11.2.4 Pharmaron Inc. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.2.5 Pharmaron Inc. Recent Development
11.3 Shanghai Model Organisms Center, Inc.
11.3.1 Shanghai Model Organisms Center, Inc. Company Details
11.3.2 Shanghai Model Organisms Center, Inc. Business Overview
11.3.3 Shanghai Model Organisms Center, Inc. Genetically Modified Experimental Animal Model Introduction
11.3.4 Shanghai Model Organisms Center, Inc. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.3.5 Shanghai Model Organisms Center, Inc. Recent Development
11.4 Sichuan Hengshu Bio-Technology Co.,Ltd.
11.4.1 Sichuan Hengshu Bio-Technology Co.,Ltd. Company Details
11.4.2 Sichuan Hengshu Bio-Technology Co.,Ltd. Business Overview
11.4.3 Sichuan Hengshu Bio-Technology Co.,Ltd. Genetically Modified Experimental Animal Model Introduction
11.4.4 Sichuan Hengshu Bio-Technology Co.,Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.4.5 Sichuan Hengshu Bio-Technology Co.,Ltd. Recent Development
11.5 China Environmental Technology and Bioenergy Holdings Limited
11.5.1 China Environmental Technology and Bioenergy Holdings Limited Company Details
11.5.2 China Environmental Technology and Bioenergy Holdings Limited Business Overview
11.5.3 China Environmental Technology and Bioenergy Holdings Limited Genetically Modified Experimental Animal Model Introduction
11.5.4 China Environmental Technology and Bioenergy Holdings Limited Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.5.5 China Environmental Technology and Bioenergy Holdings Limited Recent Development
11.6 GemPharmatech Co., Ltd.
11.6.1 GemPharmatech Co., Ltd. Company Details
11.6.2 GemPharmatech Co., Ltd. Business Overview
11.6.3 GemPharmatech Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.6.4 GemPharmatech Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.6.5 GemPharmatech Co., Ltd. Recent Development
11.7 Beijing Vital River Laboratory Animal Technology Co., Ltd.
11.7.1 Beijing Vital River Laboratory Animal Technology Co., Ltd. Company Details
11.7.2 Beijing Vital River Laboratory Animal Technology Co., Ltd. Business Overview
11.7.3 Beijing Vital River Laboratory Animal Technology Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.7.4 Beijing Vital River Laboratory Animal Technology Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.7.5 Beijing Vital River Laboratory Animal Technology Co., Ltd. Recent Development
11.8 Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
11.8.1 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Company Details
11.8.2 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Business Overview
11.8.3 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.8.4 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.8.5 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Recent Development
11.9 Jackson Laboratory
11.9.1 Jackson Laboratory Company Details
11.9.2 Jackson Laboratory Business Overview
11.9.3 Jackson Laboratory Genetically Modified Experimental Animal Model Introduction
11.9.4 Jackson Laboratory Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.9.5 Jackson Laboratory Recent Development
11.10 Hainan Jinlinggang Biotechnology Co., Ltd.
11.10.1 Hainan Jinlinggang Biotechnology Co., Ltd. Company Details
11.10.2 Hainan Jinlinggang Biotechnology Co., Ltd. Business Overview
11.10.3 Hainan Jinlinggang Biotechnology Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.10.4 Hainan Jinlinggang Biotechnology Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.10.5 Hainan Jinlinggang Biotechnology Co., Ltd. Recent Development
11.11 Guangdong Landau Biotechnology Co. Ltd.
11.11.1 Guangdong Landau Biotechnology Co. Ltd. Company Details
11.11.2 Guangdong Landau Biotechnology Co. Ltd. Business Overview
11.11.3 Guangdong Landau Biotechnology Co. Ltd. Genetically Modified Experimental Animal Model Introduction
11.11.4 Guangdong Landau Biotechnology Co. Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.11.5 Guangdong Landau Biotechnology Co. Ltd. Recent Development
11.12 Hubei Topgene Biotechnology Co., Ltd.
11.12.1 Hubei Topgene Biotechnology Co., Ltd. Company Details
11.12.2 Hubei Topgene Biotechnology Co., Ltd. Business Overview
11.12.3 Hubei Topgene Biotechnology Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.12.4 Hubei Topgene Biotechnology Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.12.5 Hubei Topgene Biotechnology Co., Ltd. Recent Development
11.13 Envigo
11.13.1 Envigo Company Details
11.13.2 Envigo Business Overview
11.13.3 Envigo Genetically Modified Experimental Animal Model Introduction
11.13.4 Envigo Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.13.5 Envigo Recent Development
11.14 Shanghai Slack Experimental Animal Co., Ltd.
11.14.1 Shanghai Slack Experimental Animal Co., Ltd. Company Details
11.14.2 Shanghai Slack Experimental Animal Co., Ltd. Business Overview
11.14.3 Shanghai Slack Experimental Animal Co., Ltd. Genetically Modified Experimental Animal Model Introduction
11.14.4 Shanghai Slack Experimental Animal Co., Ltd. Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.14.5 Shanghai Slack Experimental Animal Co., Ltd. Recent Development
11.15 Janvier Labs
11.15.1 Janvier Labs Company Details
11.15.2 Janvier Labs Business Overview
11.15.3 Janvier Labs Genetically Modified Experimental Animal Model Introduction
11.15.4 Janvier Labs Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.15.5 Janvier Labs Recent Development
11.16 Taconic Biosciences
11.16.1 Taconic Biosciences Company Details
11.16.2 Taconic Biosciences Business Overview
11.16.3 Taconic Biosciences Genetically Modified Experimental Animal Model Introduction
11.16.4 Taconic Biosciences Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.16.5 Taconic Biosciences Recent Development
11.17 Charles River Laboratories
11.17.1 Charles River Laboratories Company Details
11.17.2 Charles River Laboratories Business Overview
11.17.3 Charles River Laboratories Genetically Modified Experimental Animal Model Introduction
11.17.4 Charles River Laboratories Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.17.5 Charles River Laboratories Recent Development
11.18 Institute Of Beijing Xieerxin Biology Resource Co.ltd
11.18.1 Institute Of Beijing Xieerxin Biology Resource Co.ltd Company Details
11.18.2 Institute Of Beijing Xieerxin Biology Resource Co.ltd Business Overview
11.18.3 Institute Of Beijing Xieerxin Biology Resource Co.ltd Genetically Modified Experimental Animal Model Introduction
11.18.4 Institute Of Beijing Xieerxin Biology Resource Co.ltd Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.18.5 Institute Of Beijing Xieerxin Biology Resource Co.ltd Recent Development
11.19 PolyGene
11.19.1 PolyGene Company Details
11.19.2 PolyGene Business Overview
11.19.3 PolyGene Genetically Modified Experimental Animal Model Introduction
11.19.4 PolyGene Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.19.5 PolyGene Recent Development
11.20 Cyagen Biosciences
11.20.1 Cyagen Biosciences Company Details
11.20.2 Cyagen Biosciences Business Overview
11.20.3 Cyagen Biosciences Genetically Modified Experimental Animal Model Introduction
11.20.4 Cyagen Biosciences Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.20.5 Cyagen Biosciences Recent Development
11.21 Biocytogen
11.21.1 Biocytogen Company Details
11.21.2 Biocytogen Business Overview
11.21.3 Biocytogen Genetically Modified Experimental Animal Model Introduction
11.21.4 Biocytogen Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.21.5 Biocytogen Recent Development
11.22 Hera BioLabs
11.22.1 Hera BioLabs Company Details
11.22.2 Hera BioLabs Business Overview
11.22.3 Hera BioLabs Genetically Modified Experimental Animal Model Introduction
11.22.4 Hera BioLabs Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.22.5 Hera BioLabs Recent Development
11.23 Ozgene
11.23.1 Ozgene Company Details
11.23.2 Ozgene Business Overview
11.23.3 Ozgene Genetically Modified Experimental Animal Model Introduction
11.23.4 Ozgene Revenue in Genetically Modified Experimental Animal Model Business (2020-2025)
11.23.5 Ozgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Joinn Laboratories (China) Co., Ltd.
Pharmaron Inc.
Shanghai Model Organisms Center, Inc.
Sichuan Hengshu Bio-Technology Co.,Ltd.
China Environmental Technology and Bioenergy Holdings Limited
GemPharmatech Co., Ltd.
Beijing Vital River Laboratory Animal Technology Co., Ltd.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Jackson Laboratory
Hainan Jinlinggang Biotechnology Co., Ltd.
Guangdong Landau Biotechnology Co. Ltd.
Hubei Topgene Biotechnology Co., Ltd.
Envigo
Shanghai Slack Experimental Animal Co., Ltd.
Janvier Labs
Taconic Biosciences
Charles River Laboratories
Institute Of Beijing Xieerxin Biology Resource Co.ltd
PolyGene
Cyagen Biosciences
Biocytogen
Hera BioLabs
Ozgene
Ìý
Ìý
*If Applicable.
